CD274 and non-small cell lung carcinoma: More importantly, a notable and novel finding was reported in the PDL1-positive group, namely that related to the T-cell receptor pathway, which has been proved to be crucial for achieving a favorable immunotherapeutic response in NSCLC (Van De Ven & Borst, 2015).